Absolute Resilience 5-Month Deciphera Pharmaceuticals Inc.

Keep managed devices resilient over a defined 5-month term with Absolute Resilience for Deciphera Pharmaceuticals Inc. This license is designed for organizations that need dependable endpoint continuity, especially when device loss, tampering, or recovery gaps can interrupt operations. Absolute is known for persistence at the device level, giving IT teams a stronger foundation for maintaining control and supporting recovery workflows. For procurement teams, the value of this term-based offering is clear: it aligns cost to a specific operational window while preserving the controls needed to protect endpoints and maintain service continuity. This is a practical fit for enterprise environments where endpoint accountability matters and support teams need confidence that devices remain manageable throughout the subscription period. Rather than adding complexity, it supports a more controlled endpoint posture with a focused, time-bound deployment.